The SURMOUNT trials reported: Most common side effects: Nausea: 24% to 33% Diarrhea: 19% to 23% Constipation: 12% to 17% Vomiting: 8% to 12% Most side effects were mild to moderate and occurred primarily during the dose escalation period
Under pathological conditions, leukocyte infiltration is a promising therapeutic target
can provide the support and resources needed to succeed
Additionally, sirolimus treatment reduced fibrocyte concentration in IPF patients by 35%, showing potential for PI3K/mTOR inhibition in fibrosis management [148] (Table 2)
The UK Reference Nutrient Intake (RNI) for protein is approximately 0.75g per kilogram of body weight daily for most adults, though individual needs vary
Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function